Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,584.96
(
-0.60%
)
US TECH 100
23,618.80
(
-0.74%
)
Dow Jones
45,849.98
(
-0.81%
)
Brent Oil
107.54
(
0.90%
)
Bitcoin
69,475.68
(
-2.48%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122799
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ariadndndough post# 163271

Tuesday, 07/30/2013 11:59:55 AM

Tuesday, July 30, 2013 11:59:55 AM

Post# of 257259
MRK’s response to the Suvorexant CRL is expected in 1H14, according to today’s 2Q13 CC. The long response time is to allow MRK to develop 5mg and 10mg tablets (which did not previously exist) and test them for stability.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now